CFI-402257 is a highly selective and orally bioavailable TTK/Mps1 inhibitor with an IC50 of 1.7 nM for TTK in vitro. CFI-402257 has anti-cancer activity[1].
Molecular Weight:
498.58
Purity:
99.9600
CAS Number:
[1610759-22-2]
Formula:
C28H30N6O3
Target:
Mps1
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted